Security key
15673T100
Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share (IPSC)
CUSIP: 15673T100
Q4 2024 13F Holders as of 31 Dec 2024
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 180,747,818
- Total 13F shares
- 36,396,514
- Share change
- -3,450,296
- Total reported value
- $36,761,199
- Put/Call ratio
- 15%
- Price per share
- $1.01
- Number of holders
- 70
- Value change
- -$7,768,598
- Number of buys
- 41
- Number of sells
- 20
Report period
Q4 2024
Institutions
70
Top holders
10
IPSC full security history
Newer quarter: Q1 2025
Previous quarter: Q3 2024
Century Therapeutics, Inc. SEC filings
Century Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 15673T100
Recent filing periods:
Top shareholders of IPSC - Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC |
13F
|
Company |
3%
|
5,410,361
|
$9,251,717 | — | 30 Sep 2024 | |
| Venrock Adviser, LLC |
13F
|
Company |
3%
|
5,389,259
|
$9,215,633 | — | 30 Sep 2024 | |
| Boxer Capital, LLC |
13F
|
Company |
2.2%
|
3,900,000
|
$6,669,000 | — | 30 Sep 2024 | |
| Casdin Capital, LLC |
13F
|
Company |
1.8%
|
3,212,316
|
$5,493,060 | — | 30 Sep 2024 | |
| BlackRock, Inc. |
13F
|
Company |
1.7%
|
2,989,920
|
$5,112,764 | — | 30 Sep 2024 | |
| FMR LLC |
13F
|
Company |
1.4%
|
2,521,511
|
$4,311,784 | — | 30 Sep 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.4%
|
2,475,215
|
$4,232,618 | — | 30 Sep 2024 | |
| MORGAN STANLEY |
13F
|
Company |
1.3%
|
2,269,222
|
$3,880,370 | — | 30 Sep 2024 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.94%
|
1,704,232
|
$2,914,237 | — | 30 Sep 2024 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.73%
|
1,322,751
|
$2,261,904 | — | 30 Sep 2024 | |
| Syncona Portfolio Ltd |
13F
|
Company |
0.67%
|
1,213,056
|
$2,074,326 | — | 30 Sep 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.54%
|
968,182
|
$1,655,846 | — | 30 Sep 2024 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.5%
|
900,000
|
$1,539,000 | — | 30 Sep 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.46%
|
836,914
|
$1,431,123 | — | 30 Sep 2024 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.44%
|
797,460
|
$1,363,657 | — | 30 Sep 2024 | |
| Octagon Capital Advisors LP |
13F
|
Company |
0.37%
|
666,825
|
$1,140,271 | — | 30 Sep 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.27%
|
488,200
|
$834,822 | — | 30 Sep 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.2%
|
355,331
|
$607,616 | — | 30 Sep 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.2%
|
352,512
|
$602,795 | — | 30 Sep 2024 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.14%
|
257,600
|
$440,496 | — | 30 Sep 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.09%
|
166,123
|
$284,071 | — | 30 Sep 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.08%
|
140,759
|
$240,698 | — | 30 Sep 2024 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.07%
|
119,384
|
$202,000 | — | 30 Sep 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.06%
|
108,120
|
$184,885 | — | 30 Sep 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.06%
|
105,994
|
$181,250 | — | 30 Sep 2024 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.06%
|
105,697
|
$180,742 | — | 30 Sep 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.06%
|
105,650
|
$180,662 | — | 30 Sep 2024 | |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC |
13F
|
Company |
0.04%
|
78,210
|
$133,739 | — | 30 Sep 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.04%
|
71,721
|
$122,642 | — | 30 Sep 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.03%
|
61,945
|
$105,926 | — | 30 Sep 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.03%
|
49,862
|
$85,256 | — | 30 Sep 2024 | |
| CITIGROUP INC |
13F
|
Company |
0.02%
|
34,087
|
$58,289 | — | 30 Sep 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.02%
|
33,449
|
$56,868 | — | 30 Sep 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.02%
|
31,577
|
$53,997 | — | 30 Sep 2024 | |
| HARBOURVEST PARTNERS LLC |
13F
|
Company |
0.02%
|
29,018
|
$49,621 | — | 30 Sep 2024 | |
| Parametrica Management Ltd |
13F
|
Company |
0.02%
|
27,840
|
$47,606 | — | 30 Sep 2024 | |
| CORNERCAP INVESTMENT COUNSEL INC |
13F
|
Company |
0.01%
|
25,978
|
$44,422 | — | 30 Sep 2024 | |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. |
13F
|
Company |
0.01%
|
25,137
|
$42,984 | — | 30 Sep 2024 | |
| Corebridge Financial, Inc. |
13F
|
Company |
0.01%
|
25,022
|
$42,788 | — | 30 Sep 2024 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
22,291
|
$38,118 | — | 30 Sep 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.01%
|
22,235
|
$38,022 | — | 30 Sep 2024 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.01%
|
20,861
|
$35,672 | — | 30 Sep 2024 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.01%
|
20,020
|
$34,234 | — | 30 Sep 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.01%
|
19,519
|
$33,377 | — | 30 Sep 2024 | |
| Lynx1 Capital Management LP |
13F
|
Company |
0.01%
|
19,028
|
$32,538 | — | 30 Sep 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.01%
|
18,486
|
$31,611 | — | 30 Sep 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.01%
|
18,044
|
$30,855 | — | 30 Sep 2024 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.01%
|
17,437
|
$29,817 | — | 30 Sep 2024 | |
| SG Americas Securities, LLC |
13F
|
Company |
0.01%
|
16,081
|
$27,000 | — | 30 Sep 2024 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.01%
|
15,150
|
$25,907 | — | 30 Sep 2024 |
Institutional Holders of Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share (IPSC) as of Q4 2024
As of 31 Dec 2024,
Century Therapeutics, Inc. - Common Stock, par value $0.0001 per share (IPSC) was held by
70 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
36,396,514 shares.
The largest 10 holders included
Bain Capital Life Sciences Investors, LLC, Casdin Capital, LLC, VR Adviser, LLC, BlackRock, Inc., FMR LLC, VANGUARD GROUP INC, DAFNA Capital Management LLC, MILLENNIUM MANAGEMENT LLC, Syncona Portfolio Ltd, and RENAISSANCE TECHNOLOGIES LLC.
This page lists
70
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
66
Q4 2024 holders
70
Holder diff
4
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 Value $ | Q4 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.